<ѻýҕl>Stopping Beta-Blockers Did Not Go as Planned for Long-Time Usersѻýҕl> No benefit to beta-blocker interruption among MI survivors using them for secondary prevention Aug 30, 2024
<ѻýҕl>Wegovy Protects Against Deadly COVID Casesѻýҕl> Non-cardiovascular benefits observed in SELECT trial Aug 30, 2024
<ѻýҕl>No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh Inѻýҕl> Two trials read out, but generalizability is the question Aug 29, 2023
<ѻýҕl>Cancer Therapy's Lower-Limb Blood Clots Better Treated With Long Anticoagulationѻýҕl> A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial Aug 29, 2023
<ѻýҕl>Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathyѻýҕl> Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement" Aug 29, 2023
<ѻýҕl>Compound in Beetroot Juice Fends Off Contrast-Induced AKIѻýҕl> "Provocative" results for inorganic nitrate pill shown in NITRATE-CIN trial Aug 29, 2023
<ѻýҕl>Less Atrial Pacing Doesn't Cut Afib in Sinus Node Dysfunctionѻýҕl> Trial debunks strategy for higher-risk group Aug 28, 2023
<ѻýҕl>Immune Suppressant Stumbles for Acute Myocarditis in Early Dataѻýҕl> Phase II trial might not end the story for anti-inflammatory approach, though Aug 28, 2023
<ѻýҕl>STEMI Complete Revascularization: No Point in Waitingѻýҕl> MULTISTARS AMI trial helps answer the timing question in multivessel disease treatment Aug 28, 2023
<ѻýҕl>Rush to DOACs Spells Trouble for Frail Warfarin Usersѻýҕl> Lower bleeding risk of new blood thinners did not extend to this older subgroup Aug 28, 2023
<ѻýҕl>Ambulance Routing Might Not Matter After Cardiac Arrestѻýҕl> Trial in best-case scenario setting shows sending patients to specialty centers doesn't help Aug 28, 2023
<ѻýҕl>Pulsed Field Ablation Measures Up in Head-to-Head Trialѻýҕl> Novel catheters on par with thermal ablation, but do they meet the early high hopes? Aug 28, 2023
<ѻýҕl>Afib Ablation Exceeds Expectations in Sickest Heart Failure Patientsѻýҕl> Death and surgeries delayed in end-stage heart failure Aug 28, 2023
<ѻýҕl>CRT-D Upgrade Suits Patients With Pacing-Related Heart Failureѻýҕl> BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy Aug 27, 2023
<ѻýҕl>Trial: ECMO Doesn't Save Lives in Cardiogenic Shockѻýҕl> ECLS-SHOCK trial challenges current practice, guidelines Aug 27, 2023
<ѻýҕl>Complete PCI Better for Older MI Patients Tooѻýҕl> Trial affirms advantage over culprit-lesion-only stenting in those ages 75 and up Aug 26, 2023
<ѻýҕl>Iron Infusions Narrowly Miss the Mark for Clinical Benefit in Heart Failureѻýҕl> Hard endpoints do not favor IV ferric carboxymaltose in well-powered HEART-FID Aug 26, 2023
<ѻýҕl>Colchicine Stumbles for Protecting the Heart From Thoracic Surgeryѻýҕl> Trial meets only post hoc endpoints in extending protection to non-cardiac surgeries Aug 25, 2023
<ѻýҕl>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guidelineѻýҕl> Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<ѻýҕl>Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failureѻýҕl> Heart failure with preserved ejection fraction and obesity becoming more common Aug 25, 2023
<ѻýҕl>Subclinical Afib Caught on Cardiac Devices Might Be Better Left Aloneѻýҕl> Trial shows no stroke reduction with DOAC at the cost of more adverse events Aug 25, 2023
<ѻýҕl>Full-Dose Anticoagulation Cuts VTE in Severe COVID-19ѻýҕl> But is it worthwhile without a mortality benefit? Trials present complex picture Aug 31, 2022
<ѻýҕl>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Populationѻýҕl> Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
<ѻýҕl>P2Y12 Inhibitors May Be the Better Option for Secondary Prevention in CADѻýҕl> Meta-analysis challenges central role of aspirin, researcher says Aug 30, 2022
<ѻýҕl>Muscle Pain in Statin Patients Is Usually Not Caused by the Drugѻýҕl> A meta-analysis pointed to a low incidence of drug-related pain Aug 30, 2022
<ѻýҕl>Novel Factor XIa Inhibitors Show Promise for Bleeding Riskѻýҕl> Preventing ischemic events is a less clear benefit Aug 29, 2022
<ѻýҕl>Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yetѻýҕl> Approach beats coronary access through the thigh Aug 29, 2022
<ѻýҕl>Pendulum Swings Back for FFR-Guided Complete Revascularizationѻýҕl> Modality helps avoid unnecessary intervention in heart attack patients with multivessel disease Aug 29, 2022
<ѻýҕl>Doubling Up on Heart Drugs May Delay Aortic Damage From Marfan Syndromeѻýҕl> Meta-analysis settles the confusion around angiotensin receptor blockers Aug 29, 2022
<ѻýҕl>Perfusion Tests Comparable as Second-Line Diagnostic for Chest Painѻýҕl> Head-to-head trial finds "interchangeable" accuracy Aug 29, 2022
<ѻýҕl>Routine Stress Testing Didn't Offer Benefits to High-Risk Patients Post-PCIѻýҕl> South Korean trial showed no improvement in clinical outcomes at 2 years Aug 28, 2022
<ѻýҕl>High-Dose Flu Vaccine Promising for Mortality Benefits in Older Adultsѻýҕl> Danish pilot study lays groundwork for larger trial looking for better CV outcomes Aug 28, 2022
<ѻýҕl>Extravascular ICD Gains Ground in Unfamiliar Territoryѻýҕl> Inappropriate shocks among early challenges of device therapy under the sternum Aug 28, 2022
<ѻýҕl>Xarelto Risky in Rheumatic Heart Diseaseѻýҕl> Ischemic event prevention didn't pan out in INVICTUS trial Aug 28, 2022
<ѻýҕl>Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EFѻýҕl> SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
<ѻýҕl>ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HFѻýҕl> Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
<ѻýҕl>PCI Flops for Ischemic LV Dysfunction With Coronary Artery Diseaseѻýҕl> Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
<ѻýҕl>Mass Cardiovascular Testing May Add Years for Some Menѻýҕl> Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
<ѻýҕl>After Cardiac Arrest, No 'Best' Blood Pressure, Oxygen Targetѻýҕl> BOX trial finds targets aiming to boost perfusion held no advantage Aug 27, 2022
<ѻýҕl>Breakfast or Bedtime BP Meds? Timing Doesn't Matter After Allѻýҕl> TIME study supports taking antihypertensives whenever convenient Aug 26, 2022